Suppr超能文献

米氮平成功治疗一名81岁抗利尿激素分泌异常综合征患者。

Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.

作者信息

Jagsch C, Marksteiner J, Seiringer E, Windhager E

出版信息

Pharmacopsychiatry. 2007 May;40(3):129-31. doi: 10.1055/s-2007-973837.

Abstract

Elderly patients are at a higher risk for inappropriate antidiuretic hormone secretion when treated with antidepressants. In response to severe depressive symptoms, we initiated treatment with citalopram of an 81-year-old female patient with slightly reduced sodium and chloride levels. The sodium and chloride levels decreased continuously during treatment with citalopram; six days after the citalopram was discontinued, sodium and chloride levels returned to normal. We then switched treatment to mirtazapine. Close monitoring revealed that the patient's sodium and chloride levels never decreased and the patient did not relapse for more than two months. This case study indicates that treatment with citalopram may worsen preexisting hyponatremia. Mirtazapine appears to be safe for use in high-risk, elderly patients.

摘要

老年患者在使用抗抑郁药治疗时发生抗利尿激素分泌不当的风险较高。针对一名81岁女性患者严重的抑郁症状,我们开始使用西酞普兰进行治疗,该患者的钠和氯水平略有降低。在使用西酞普兰治疗期间,钠和氯水平持续下降;停用西酞普兰六天后,钠和氯水平恢复正常。然后我们改用米氮平进行治疗。密切监测显示,患者的钠和氯水平从未下降,且患者在两个多月内未复发。该病例研究表明,使用西酞普兰治疗可能会使已有的低钠血症恶化。米氮平似乎对高危老年患者的使用是安全的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验